Evidence receipt / belief
Published Ā· transcript-backedSpeaker unverified: belief
12 Feb 2026 Latent Space š¬Beyond AlphaFold: How Boltz is Open-Sourcing the Future of Drug Discovery
āOn the other hand, kind of going to your question of, you know, why do we care about, you know, how the protein falls or, you know, how the car is made to some extent is that, you know, sometimes when something goes wrong, you know, there are, you know, cases of, you know, proteins misfolding.ā
ā Speaker unverified
Source trail
Everything needed to verify it.
- Speaker
- Speaker unverified
- Attribution
- Not verified from this transcript
- Claim type
- belief
- Recorded
- 12 Feb 2026
- Publisher
- Latent Space
Transcript context
ā¦same time, it was really only the beginning. So you can say, like, what was the specific problem you would argue was solved? And then, like, you know, what is remaining, which is probably quite open. I think weāll steer away from the term solved, because we have many friends in the community who get pretty upset at that word. And I think, you know, fairly so. But the problem that was, you know, that a lot of progress was made on was the ability to predict the structure of single chain proteins. So proteins can, like, be composed of many chains. And single chain proteins are, you know, just a single sequence of amino acids. And one of the reasons that weāve been able to make such progress is also because we take a lot of hints from evolution. So the way the models work is that, you know, they sort of decode a lot of hints. That comes from evolutionary landscapes. So if you have, like, you know, some protein in an animal, and you go find the similar protein across, like, you know, different organisms, you might find different mutations in them. And as it turns out, if you take a lot of the sequences together, and you analyze them, you see that some positions in the sequence tend to evolve at the same time as other positions in the sequence, sort of this, like, correlation between different positions. And it turns out that that is typically a hint that these two positions are close in three dimension. So part of the, you know, part of the breakthrough has been, like, our ability to also decode that very, very effectively. But what it implies also is that in absence of that co-evolutionary landscape, the models donāt quite perform as well. And so, you know, I think when that information is available, maybe one could say, you know, the problem is, like, somewhat solved. From the perspective of structure prediction, when it isnāt, itās much more challenging. And I think itās also worth also differentiating the, sometimes we confound a little bit, structure prediction and folding. Folding is the more complex process of actually understanding, like, how it goes from, like, this disordered state into, like, a structured, like, state. And that I donāt think weāve made that much progress on. But the idea of, like, yeah, going straight to the answer, weāve become pretty good at. So thereās this protein that is, like, just a long chain and it folds up. Yeah. And so weāre good at getting from that long chain in whatever form it was originally to the thing. But we donāt know how it necessarily gets to that state. And there might be intermediate states that itās in sometimes that weāre not aware of. g chain in whatever form it was originally to the thing. But we donāt know how it necessarily gets to that state. And there might be intermediate states that itās in sometimes that weāre not aware of. Thatās right. And that relates also to, like, you know, our general ability to model, like, the different, you know, proteins are not static. They move, they take different shapes based on their energy states. And I think we are, also not that good at understanding the different states that the protein can be in and at what frequency, what probability. So I think the two problems are quite related in some ways. Still a lot to solve. But I think it was very surprising at the time, you know, that even with these evolutionary hints that we were able to, you know, to make such dramatic progress. So I want to ask, why does the intermediate states matter? But first, I kind of want to understand, why do we care? What proteins are shaped like? Yeah, I mean, the proteins are kind of the machines of our body. You know, the way that all the processes that we have in our cells, you know, work is typically through proteins, sometimes other molecules, sort of intermediate interactions. And through that interactions, we have all sorts of cell functions. And so when we try to understand, you know, a lot of biology, how our body works, how disease work. So we often try to boil it down to, okay, what is going right in case of, you know, our normal biological function and what is going wrong in case of the disease state. And we boil it down to kind of, you know, proteins and kind of other molecules and their interaction. And so when we try predicting the structure of proteins, itās critical to, you know, have an understanding of kind of those interactions. Itās a bit like seeing the difference between... Having kind of a list of parts that you would put it in a car and seeing kind of the car in its final form, you know, seeing the car really helps you understand what it does. On the other hand, kind of going to your question of, you know, why do we care about, you know, how the protein falls or, you know, how the car is made to some extent is that, you know, sometimes when something goes wrong, you know, there are, you know, cases of, you know, proteins misfolding. In some diseases and so on, if we donāt understand this folding process, we donāt really know how to intervene. Thereās this nice line in the, I think itās in the Alpha Fold 2 manuscript, where they sort of discuss also like why we even hopeful that we can target the problem in the first place. And then thereās this notion that like, well, four proteins that fold. The folding process is almost instantaneous, which is a strong, like, you know, signal that like, yeah, like we should, we might be... able to predict that this very like constrained thing that, that the protein does so quickly. And of course thatās not the case for, you know, for, for all proteins. And thereās a lot of like really interesting mechanisms in the cells, but yeah, I remember reading that and thought, yeah, thatās somewhat of an insightful point. for, you know, for, for all proteins. And thereās a lot of like really interesting mechanisms in the cells, but yeah, I remember reading that and thought, yeah, thatās somewhat of an insightful point. I think one of the interesting things about the protein folding problem is that it used to be actually studied. And part of the reason why people thought it was impossible, it used to be studied as kind of like a classical example. Of like an MP problem. Uh, like there are so many different, you know, type of, you know, shapes that, you know, this amino acid could take. And so, this grows combinatorially with the size of the sequence. And so there used to be kind of a lot of actually kind of more theoretical computer science thinking about and studying protein folding as an MP problem. And so it was very surprising also from that perspective, kind of seeing. Machine learning so clear, there is some, you know, signal in those sequences, through evolution, but also through kind of other things that, you know, us as humans, weāre probably not really able to, uh, to understand, but that is, models Iāve, Iāve learned. And so Andrew White, we were talking to him a few weeks ago and he said that he was following the development of this and that there were actually ASICs that were developed just to solve this problem. So, again, that there were. There were many, many, many millions of computational hours spent trying to solve this problem before AlphaFold. And just to be clear, one thing that you mentioned was that thereās this kind of co-evolution of mutations and that you see this again and again in different species. So explain why does that give us a good hint that theyāre close by to each other? Yeah. Um, like think of it this way that, you know, if I have, you know, some amino acid that mutates, itās going to impact everything around it. Right. In three dimensions. And so itās almost like the protein through several, probably random mutations and evolution, like, you know, ends up sort of figuring out that this other amino acid needs to change as well for the structure to be conserved. Uh, so this whole principle is that the structure is probably largely conserved, you know, because thereās this function associated with it. And so itās really sort of like different positions compensating for, for each other. I see. Those hints in aggregate give us a lot. Yeah. So you can start to look at what kinds of information about what is close to each other, and then you can start to look at what kinds of folds are possible given the structure and then what is the end state.ā¦
Stored transcript either side of the excerpt. The highlighted words are the published quote; the surrounding text is unedited source, never generated.